Teal Health’s Post

We're thrilled to share that Teal Health has been selected as a spoke in the ARPA-H Investor Catalyst Hub network! We are excited to join this nationwide effort focused on driving innovative advancements in science and medicine, bringing us closer to equitable healthcare and better outcomes for all. #ARPAH #ARPANETH #MedTech #HealthTech #InvestorCatalystHub #HealthInnovation

We are excited to share that Teal Health won the pitch contest during the Culture Shifting Summit in Silicon Valley last week. The Culture Shifting Summit celebrates innovation and diversity, providing a platform for underrepresented voices to come together to make big changes in the venture and startup community. It was wonderful to be in a room of so many inspiring people and to have them recognize the importance of Teal Health's solution in transforming healthcare access for women. #CultureShiftingSummit #DiversityInTech #TealHealth #WomenInHealthcare #CervicalCancerAwareness #HealthEquity #InnovatingHealthcare

We’re excited to be highlighted in this article from The New York Times, outlining the evolution and new innovations in cervical cancer screenings. The future of at-home testing is within reach and we’re proud that Teal Health is leading the way, striving to bring the first FDA-approved at-home cervical cancer screening to all women across the United States. Check out the article by Danielle Friedman to learn more about this alternative to the in-office pap smear. #tealhealth #womenshealth #papsmear #cervicalcancerscreening #femtech https://lnkd.in/ebxUwsN7

Thank you Dezeen for showcasing the design of our Teal Wand at-home cervical cancer screening device. Changing an 80+ year Pap smear experience and replacing an 150+ year old speculum takes some creative thinking and thoughtful research. We have a great design partner in IDEO, who shares in our vision to ensure the design is intuitive and comfortable for all body types and health literacy levels. The Teal Wand has since been through multiple clinical trials, including a nationwide study across 17 leading medical organizations and has led to receiving Breakthrough Device Designation from the FDA. We believe in the power of design and can't wait to get the Teal Wand in the hands of people who need it. https://lnkd.in/gj3e6wvE

We are honored to be among the founding members of the Biospecimen Management Consortium (BMC), which will work to develop best practices and standards across the industry; streamline biospecimen lifecycle operations and data management; and shape regulatory policy. At Teal, we are passionate about innovating in the women's health space and advancing clinical research. 

As we announced last month, our nationwide SELF-CERV study completed enrollment ahead of schedule, while exceeding initial enrollment projections. This was made possible because of the exceptional teams at our study sites and the amazing women who raised their hands to participate. Additionally, we had great partners, like Slope to ensure the operations and logistics ran smoothly. Our very own Trena Depel recently participated in Slope Clinical’s Advisory meeting to discuss the value that using Slope’s biospecimen sample management platform brought to our study. Slope is dedicated to driving best practices in biospecimen management and was an invaluable partner to the rapid and successful enrollment of SELF-CERV, with over 1,000 samples to manage. Our clinical sites loved the simplicity of ordering supplies, logging samples, and managing shipments using the Slope platform, and Teal Health appreciated the real-time metrics to understand enrollment and sample movement across our 17 clinical sites and multiple labs. We will certainly be using Slope for our future studies as well. Here are a few highlights of the benefits we measured.

Thank you Fast Company for showcasing our at-home cervical cancer screening device and our telehealth service. There is so much potential to increase screening rates and reduce cervical cancer incidence in the US, using at-home screening, virtual provider support, and care navigation to in-person follow-up care (when appropriate). We are excited for the journey ahead! https://lnkd.in/g4qnqXck

We're proud to partner with Evvy and many other companies as part of the #EqualResearchDay Collaborative this year. Addressing the gender health gap requires a collective effort, and while our work is just beginning, it's incredibly inspiring to see the dedication and energy committed to this shared mission. #womenshealth #genderhealthgap #womensresearch

The good news keeps on coming! Last week, we announced our FDA Breakthrough Designation for our at-home self-collect cervical cancer screening device and yesterday, Roche and BD announced they have received FDA approval for their in-clinic self-collect cervical cancer screening methods. Our Breakthrough Designation grants us priority review with the FDA once we submit our final study data, and the in-clinic approval is an important first step in helping to bring at-home screening through the FDA. Our clinical trial was run on both the Roche and BD Primary HPV assays. We are thrilled for Roche and BD and congratulate them on this important work to expand screening options for women and people with a cervix. #womenshealth #tealhealth #femtech https://lnkd.in/ep7CVdKG

World Changing Ideas! Thank you Fast Company for recognizing Teal Health for our efforts to increase access and improve the cervical cancer screening experience in the US. As we have shared before, self-collect cervical cancer screening is already being used in 17 countries across the globe and proving to be instrumental in increasing screening rates and decreasing cervical cancer incidence. We are honored to be among the efforts in the US to activate REAL POSITIVE CHANGE for this critical life-saving screening. #womenshealth #femtech https://lnkd.in/dnZETN9G